You are currently viewing a new version of our website. To view the old version click .
Molecules
  • Correction
  • Open Access

9 December 2022

Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597

,
,
and
1
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA
2
Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt
3
Department of Hematology/Pediatric Oncology, Yousef Abdulatif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia
*
Author to whom correspondence should be addressed.

Error in Figure

In the original publication [1], there was an error in the representative images for PBS (control) and RQ-NPs (10× and 40×), which were mistakenly duplicated while arranging the figure from the control and the RQ-NPs sets of the cardiac tissue slice images. Corrected representative images at 10× and 40× are placed from the RQ-NP treated group cardiac tissue slices. The authors apologize for this unintentional mistake. These changes in the representative images do not affect the conclusions regarding the biological activity of the RQ-NP with or without Dox studied as shown in Figure 6.
Corrected Figure 6:
Molecules 27 08730 i001

Reference

  1. Godugu, K.; El-Far, A.H.; Al Jaouni, S.; Mousa, S.A. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.